Cavendish sees IXICO forecasts as conservative after order book hits five-year high

Shares in IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging and biomarker analytics specialist, rose as much as 11% after interim results showed the company's order book at its highest level since 2021, prompting its house broker to describe full-year estimates as conservative. The company reported revenue up 23% to £3.9 million in the six months to 31 March, with gross margin improving to 53.2% from 49.6% as a higher proportion of analysis-related work, which carries stronger margins, came through the mix.